VolitionRx Limited (VNRX)

$0.70 3.00% $0.02 Healthcare

VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating samples for more accurate diagnosis; and Nu.Q Discover, a solution to profiling nucleosomes. The company operates Nucleosomics a technology platform for blood test. VolitionRx Limited is based in Austin, Texas.

$64.47M

Mr. Cameron Reynolds MBA

83.00

Austin, TX

Feb 06, 2015

-1.75

$-0.40

1.05

1.14

-6,409.37%

-1.36

0.02

7.73

101.71

1.06

-120.59%

-3,142.32%

Similar stocks (3)

Evolus, Inc.

EOLS

$16.77 -4.12%
Uptrend

OncoCyte Corporation

OCX

$3.15 2.94%
Neutral

electroCore, Inc.

ECOR

$6.20 2.48%
Downtrend

ETF Exposure (2)

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

0%

$134.52 1.86%
Uptrend

Vanguard Extended Market Index Fund

VXF

0%

$178.36 0.55%
Uptrend